How is the Y-Mabs Therapeutics Inc today?

The Y-Mabs Therapeutics Inc today is trading in the green, up by 6.22% at 4.10.

How has Y-Mabs Therapeutics Inc performed historically?

The Y-Mabs Therapeutics Inc is currently trading up 6.22% on an intraday basis in the past week the index rose 5.40%. The index has been down -34.29% in the past quarter and fell -65.40% in the past year. You can view this in the overview section.

What is Y-Mabs Therapeutics Inc Annual Revenue?

Y-Mabs Therapeutics Inc Annual Revenue rose 3.38%, in the last year to $87.68 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is Y-Mabs Therapeutics Inc Annual Net Profit?

Y-Mabs Therapeutics Inc Annual Net Profit fell 38.45% in the last year to $29.67 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is Y-Mabs Therapeutics Inc Price to Earning Ratio?

Y-Mabs Therapeutics Inc Price to Earning Ratio is -6.26, which is negative.

What is Y-Mabs Therapeutics Inc Stock Price?

Y-Mabs Therapeutics Inc Stock Price fell 65.4% and underperformed its sector by 74.26% in the past year.

What is Y-Mabs Therapeutics Inc Quarterly Revenue?

Y-Mabs Therapeutics Inc Quarterly Revenue rose 13.41% YoY to $26.5 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is Y-Mabs Therapeutics Inc Quarterly Net profit?

Y-Mabs Therapeutics Inc Quarterly Net profit fell 587.25% YoY to $6.79 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is Y-Mabs Therapeutics Inc Debt to Equity Ratio?

Y-Mabs Therapeutics Inc Debt to Equity Ratio of 0.01 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Y-Mabs Therapeutics Inc Return on Equity(ROE)?

Y-Mabs Therapeutics Inc Return on Equity(ROE) for the last financial year was -30.74%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Y-Mabs Therapeutics Inc Mutual Fund Holding?

Y-Mabs Therapeutics Inc Mutual Fund Holding decreased by 1.98% in the last quarter to 34.4.

What is Y-Mabs Therapeutics Inc Promoter Share Holding?

Y-Mabs Therapeutics Inc Promoter Share Holding decreased by 0.04% in the most recent quarter to 1.61%.

What is Y-Mabs Therapeutics Inc Institutional Holding?

Y-Mabs Therapeutics Inc Institutional Holding decreased by 0.16% in the last quarter to 57.2.

Y-Mabs Therapeutics Inc XNAS: YMAB

Y-Mabs Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Y-Mabs Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Y-Mabs Therapeutics Inc
Rating: 1.104013875
Author: Trendlyne DVM scores

Weak Stock

about

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

4.10 0.24 (6.22%)

New 52W Low in past week

224.8K XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Low Financial Strength

22.2 / 100

Expensive Valuation

19.2 / 100

Technically Bearish

24.7 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 280%

10 analysts

Y-Mabs Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Y-Mabs Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved prod...

New 52W Low in past week

SWOT Analysis

Y-Mabs Therapeutics Inc Live Price Chart

Y-Mabs Therapeutics Inc FAQ

How is Y-Mabs Therapeutics Inc today?

Y-Mabs Therapeutics Inc today is trading in the green, and is up by 6.22% at 4.10.

How has Y-Mabs Therapeutics Inc performed historically?

Y-Mabs Therapeutics Inc is currently trading up 6.22% on an intraday basis. In the past week the stock rose 5.40%. stock has been down -34.29% in the past quarter and fell -65.40% in the past year. You can view this in the overview section.